Timber Pharmaceuticals, Inc.(NYSE Amex Equities : TMBR)
(
)
Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | -0.43% | 166.86 | 0.7% | $1081.06m | |
| PFE | Pfizer Inc. | -1.38% | 48.59 | 0.9% | $912.26m | |
| LLY | Eli Lilly & Co. | 0.04% | 316.96 | 1.1% | $820.24m | |
| MRK | Merck & Co., Inc. | 0.42% | 91.42 | 0.7% | $782.30m | |
| ABBV | AbbVie, Inc. | -0.04% | 141.39 | 1.9% | $776.62m | |
| BMY | Bristol-Myers Squibb Co. | -0.55% | 74.15 | 1.0% | $614.48m | |
| SIGA | SIGA Technologies, Inc. | -6.42% | 23.18 | 0.0% | $439.36m | |
| AZN | AstraZeneca Plc | 0.12% | 66.50 | 1.0% | $365.07m | |
| GBT | Global Blood Therapeutics, Inc. | 0.08% | 67.05 | 5.6% | $352.06m | |
| GSK | GSK Plc | -0.17% | 34.25 | 0.3% | $285.96m | |
| ALNY | Alnylam Pharmaceuticals, Inc. | 0.14% | 223.45 | 8.2% | $270.68m | |
| HZNP | Horizon Therapeutics Plc | -0.84% | 61.21 | 5.4% | $225.68m | |
| CCXI | ChemoCentryx, Inc. | 0.43% | 51.00 | 2.9% | $213.70m | |
| KRTX | Karuna Therapeutics, Inc. | -0.08% | 261.01 | 0.0% | $204.69m | |
| VERU | Veru, Inc. | -21.47% | 18.68 | 0.0% | $196.18m |
Company Profile
Timber Pharmaceuticals, Inc. operates as a biopharmaceutical company focused on the development and commercialization of treatments for orphan dermatologic diseases. Its initial focus is on developing non-systemic treatments for rare dermatologic diseases, including congenital ichthyosis, facial angiofibromas in tuberous sclerosis complex, and other sclerotic skin diseases. The company was founded in 2019 and is headquartered in Basking Ridge, NJ.